Additional Proxy Soliciting Materials (definitive) (defa14a)
April 28 2023 - 8:27AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the
Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ |
Preliminary Proxy Statement |
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2)) |
☐ |
Definitive Proxy Statement |
☒ |
Definitive Additional Materials |
☐ |
Soliciting Material Pursuant to §240.14a-12 |
VIRIDIAN THERAPEUTICS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
☐ |
Fee paid previously with preliminary materials. |
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
14a-6(i)(1) and 0-11. |
VIRIDIAN THERAPEUTICS, INC.
221 CRESCENT STREET, SUITE 401
WALTHAM, MA 02453
V15463-P93517
You
invested in VIRIDIAN THERAPEUTICS, INC. and its time to vote!
You have the right to vote on proposals
being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on June 14, 2023.
Get informed before you vote
View the Proxy Statement, Notice and Annual Report online OR you can receive a free paper or email copy of the
material(s) by requesting prior to May 31, 2023. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line.
Unless requested, you will not otherwise receive a paper or email copy.
* Please check the meeting materials for any special requirements for meeting attendance.
V1
Vote at www.ProxyVote.com
THIS IS NOT A VOTABLE BALLOT
This is an overview of the more complete proxy materials that are available to you on the Internet.
You may view the proxy materials at www.ProxyVote.com or easily request a paper copy. We encourage you to access and review all of the important information contained in the proxy materials before voting. Please follow the instructions on the
reverse side to vote on these important matters.
|
|
|
|
|
|
|
|
|
|
|
Voting Items |
|
|
|
|
|
Board
Recommends |
|
|
|
|
1. |
|
To elect the two Class II director nominees to serve until the 2026 Annual Meeting of Stockholders. |
|
|
|
|
|
|
Nominees: |
|
|
|
|
|
|
|
For |
|
|
|
|
|
|
|
|
01) Tomas Kiselak
02) Jennifer K. Moses |
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
To ratify the selection of KPMG LLP as the Companys independent registered public accounting firm for the year ending December 31,
2023. |
|
|
|
For |
|
|
|
|
3. |
|
To approve, on an advisory basis, the compensation of the Companys named executive officers. |
|
|
|
For |
|
|
|
|
4. |
|
To approve a further amendment and restatement of the Companys Amended and Restated 2016 Equity Incentive Plan, including to
increase the number of shares available for issuance thereunder. |
|
|
|
For |
|
|
|
Note: To transact such other business as may properly come before the meeting or any adjournment or postponement
thereof. |
|
|
|
|
|
|
|
|
|
|
Prefer to
receive an email instead? While voting on www.ProxyVote.com, be sure to click Delivery Settings. |
V15464-P93517
Miragen Therapeutics (NASDAQ:MGEN)
Historical Stock Chart
From Jul 2024 to Aug 2024
Miragen Therapeutics (NASDAQ:MGEN)
Historical Stock Chart
From Aug 2023 to Aug 2024